Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ
Closed
Oct 23, 2026
Day's Range
13.2052 wk Range
12.79Overview - SNDX - Syndax Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
1.55B
P/E (Trailing)
-5.02
P/E (Forward)
-19.89
PEG Ratio
0.14
Price / Sales (TTM)
6.01
Price / Book
100.53
EV / EBITDA
-7.99
Profitability
Gross Margin
95.59%
Profit Margin
-87.51%
Operating Margin
-54.94%
Return on Assets
-18.67%
Return on Equity
-255.92%
Ownership
Shares Outstanding
89.15M
Float
80.29M
Short % of Shares Outstanding
20.78%
Held by Insiders
1.68%
Held by Institutions
125.97%
Price stats
Beta
0.42
50-Day Avg
19.00
200-Day Avg
20.79
Dividends
Payout Ratio
0.00%
Analyst Consensus
12 analysts
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SNDX - Syndax Pharmaceuticals, Inc.
Peers - SNDX - Syndax Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- SNDXNASDAQSyndax Pharmaceuticals, Inc.1.47BMarket Cap+7.49%52-week change-5.03P/E (Trailing)-87.51%Profit Margin
- ARGXNASDAQArgenx SE54.66BMarket Cap+4.54%52-week change30.26P/E (Trailing)31.73%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.97BMarket Cap-110.32%52-week change37.78P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - SNDX - Syndax Pharmaceuticals, Inc.
About
Syndax Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative cancer therapies. Its current portfolio centers on treatments for hematologic malignancies and serious immune-related conditions, with products that address acute leukemias and chronic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
